March Recruitment Update
Graph displaying the screening and randomisation of Octopus trial participants from January 2023 to March 2024.
We have reached 219 participants screened and 165 randomised!
Special recognition goes out to Belfast City Hospital and University Hospital Southampton Octopus site staff who have been consistently randomising participants every month!
This means we have screened enough participants to cover one arm of the trial (>125).
Octopus is on track to successfully randomise 375 participants for the Analysis Stage 1.
Check out the table below to see how each site is doing as of 11-March-2024:
| Site | Number Screened | Number Randomised |
| UCLH (London) | 96 | 77 |
| University Hospital Southampton (Southampton) | 22 | 16 |
| The Anne Rowling Regenerative Neurology clinic (Edinburgh) | 25 | 15 |
| Royal Hallamshire Hospital (Sheffield) | 13 | 12 |
| Belfast City Hospital (Belfast) | 20 | 16 |
| Leeds General Infirmary (Leeds) | 12 | 8 |
| University of Wales (Cardiff) | 8 | 6 |
| Poole Hospital (Poole) | 7 | 5 |
| University Hospital Coventry and Warwickshire (Coventry) | 5 | 4 |
| Addenbrooke's Hospital (Cambridge) | 3 | 2 |
| Queen's Medical Centre (Nottingham) | 2 | 2 |
| Royal Victoria Infirmary (Newcastle) | 6 | 2 |
| Total | 219 | 165 |
